Lecture Details - Table of Contents
13th Annual Fall Oncology Conference: Clinical Challenges in Cancer Medicine
Release Date: October 11, 2009| Oct 2-4, 2009, Hilton Head Island, SC
Table of Contents
Debate: The Most Appropriate Management Strategy for Advanced Breast Cancer Is Single-Agent Therapy - Pro/Con
G. Thomas Budd
Debate: Patients With Colorectal Cancer and Unresectable Liver Metastases Should Receive Antiangiogenic Therapy Only in Combination With Chemotherapy as Initial Systemic Therapy - Pro
Cathy Eng
Debate: Patients With Colorectal Cancer and Unresectable Liver Metastases Should Receive Antiangiogenic Therapy Only in Combination With Chemotherapy as Initial Systemic Therapy - Con
John MacDonald
How to Choose Systemic Therapy for Advanced Renal Cell Carcinoma
Gary Hudes
State-of-the-Art Treatment in Sarcoma
Andrew J. Wagner
Molecular Markers and Treatment Decisions in Colorectal Cancer
John Macdonald
Optimizing Individualized Therapy for NSCLC
Thomas Stinchcombe
Tailoring Targeted Therapy for Breast Cancer
G. Thomas Budd
Treatment Options for Patients With Platinum-Sensitive and Platinum-Resistant Recurrent Ovarian Cancer
Robert L. Coleman
Debate: Patients With Stage IV or Recurrent NSCLC Who Respond Favorably to Initial Chemotherapy Should Receive Maintenance Therapy - Pro
Thomas Stinchcombe
Debate: Patients With Stage IV or Recurrent NSCLC Who Respond Favorably to Initial Chemotherapy Should Receive Maintenance Therapy - Con
Nasser H. Hanna
Debate: Patients With Advanced (FIGO Stage III or IV) Ovarian Carcinoma, After Surgical Bulk Reduction if Appropriate, Should Receive Systemic Therapy Consisting of Weekly Paclitaxel Plus Every-3-Week Carboplatin - Pro
Robert L. Coleman
Debate: Patients With Advanced (FIGO Stage III or IV) Ovarian Carcinoma, After Surgical Bulk Reduction if Appropriate, Should Receive Systemic Therapy Consisting of Weekly Paclitaxel Plus Every-3-Week Carboplatin - Con
J. Tate Thigpen
Debate: Transplantation for Multiple Myeloma: Sooner
Jeffrey Zonder
Debate: Transplantation for Multiple Myeloma: Later
Sagar Lonial
Transplantation-Ineligible Multiple Myeloma
Sagar Lonial
Treatment Options for MCL
John P. Leonard
The Treatment Continuum in CLL
Louis Diehl
State-of-the-Art Therapy for TCL
John P. Leonard
Treatment Options for a Patient With Relapsed/Refractory ITP
Morey Blinder
Bone Health and Cancer Outcomes in Breast Cancer
Adam Brufsky
Complications of Antiangiogenic Therapy
Cathy Eng
Career Choices in Oncology: Perspective on Community Practice
Asad Dean
How to Design and Interpret Clinical Trials in the Era of Translational and Collaborative Medicine
J. Tate Thigpen
Debate: Molecular Prognostic Assays Should Trump Conventional Indexes in Decision Making for Early-Stage Breast Cancer - Pro
Ha Tran
Debate: Molecular Prognostic Assays Should Trump Conventional Indexes in Decision Making for Early-Stage Breast Cancer - Con
James B. Gatewood
Instructions for Participation
To view the streaming Flash Video lectures, click the "Listen to the Presentation Now" link. The latest version of Flash Player is recommended to view the Flash video.
Click here to download Flash Player >>
To download Podcast-ready movies, click "Download the Presentation," and select "Save target as..." The latest version of Quicktime is recommended to view these movies.
Click here to download Quicktime >>
Read all of the conditions in the Activity Terms box below. You must accept the Activity Terms in order to continue:
Disclaimer
Physicians’ Education Resource presents this resource for educational purposes only. Participants are expected to use their own expertise and judgment while engaged in the practice of medicine. Please consult full prescribing information for any drugs or procedures discussed within.
The views and opinions expressed in these presentations are those of the authors and do not necessarily reflect the views of the sponsor, supporter, or publisher. Although great care has been taken in compiling and checking the information given in this publication to ensure accuracy, the authors and Physicians’ Education Resource and its servants or agents shall not be responsible or in any way liable for the continued currency of the information or for any errors, omissions, or inaccuracies in this publication, whether arising from negligence or otherwise howsoever or for any consequences arising therefrom.
Disclosure of Unlabeled Uses
This reference may contain discussion of published and/or investigational uses of agents that are not approved by the US Food and Drug Administration. For additional information about approved uses, including approved indications, contraindications, and warnings, please refer to the prescribing information for each product, or consult the Physician’s Desk Reference.
All rights reserved; for personal use only. No part of this presentation may be translated, reproduced or transmitted by any means or in any type of media form including electronic, mechanical photocopying, recording, broadcasting, or otherwise without prior permission from the publisher.
Software Requirements
The Web pages and Web-based applications require a minimum Web browser of Microsoft Internet Explorer 5.5 or higher, Mozilla Firefox 1.0 or higher, or another compatible Web browser.
If you are not sure of the version of your browser, select Help in the menu bar of your browser, then select About.
PC UsersIf you need to upgrade your Web browser, follow one of the links listed below:
- Microsoft Internet Explorer Downloads (Outside Source)
- Mozilla Firefox Product Page (Outside Source)
- Adobe Flash Player 9 (Outside Source)
- ITunes for Podcast (Outside Source)
- Adobe Acrobat Reader (Outside Source)
Macintosh Users
Compatible Web browsers include
- Firefox (Outside Source)
- Apple Safari (Outside Source).
- Adobe Flash Player 9 (Outside Source)
- ITunes for Podcast (Outside Source)
- Adobe Acrobat Reader (Outside Source)